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Abstract
Background: The findings from studies on the relationship between aldehyde dehydrogenases(ALDH) gene Glu504Lys poly-
morphism and colorectal  cancer(CRC) were inconsistent.
Objectives: The aim of  this meta-analysis was to assess ALDH gene Glu504Lys polymorphism and CRC risk.
Methods: All of  the relevant studies were identified from PubMed and Embase database. Statistical analyses were conducted 
with STATA 12.0 software.Odds ratio (OR) with 95% confidence interval (CI) values were applied to evaluate the strength of  
the association. Nine studies with 2779 cases and 4533 controls were included.
Results: No significant variation in CRC risk was detected in any of  the genetic models overall. To explore the sources of  
heterogeneity,we performed further sub-group analyses by ethnicity and quality assessment of  these studies.In the sub-group 
analysis by race,significant associations between ALDH gene Glu504Lys polymorphism and CRC risk were found in China(Glu/
Lys vs Glu/Glu: OR = 0.70, 95%CI = 0.57–0.85; the dominant model: OR =0.69, 95%CI =0.48–0.98) and Japan(Lys/Lys vs 
Glu/Glu:OR =0.72, 95%CI =0.55–0.95).
Conclusion: This meta-analysis suggests that  the ALDH2 Glu504Lys polymorphism may be associated with susceptibility to 
CRC. Furthermore,  large and well-designed studies are needed to confirm these conclusions.
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Introduction
Colorectal cancer (CRC) is one of  the most prevailing 
cancers occurring in the digestive system,and it is ranked 
as the third worldwide primary cancer-causing death 
worldwide1. The highest morbidity of  CRC is discovered 
in Australia, Europe, and North America. In addition, the 
morbidity of  CRC is rapidly increasing in many countries 
within Eastern Asia2. CRC is a multi-step process and 
multiple factors are involved. Although etiology of  CRC 
is still not fully understood, cumulative evidence demon-
strates that the environment, life style, diet habit,and oth-
er environmental factors contribute to the pathogenesis 
of  CRC in different degrees3. In recent years,molecular 
epidemiological studies have manifested that single nucle-
otide polymorphisms (SNPs) in genes play a key role in 
CRC development and progression4. Genome-wide asso-
ciation studies (GWASs) have showed that genetic factors 
accounted for 33% of  CRC cases in the world5,6.
The primary enzymes involved in alcohol metabolism are 
alcohol dehydrogenases (ADH) and aldehyde dehydro-
genases(ALDH)7. ALDH2 is the key enzyme responsible 
for acetaldehyde elimination, and its polymorphic vari-
ants determine blood acetaldehyde concentrations after 
drinking. Therefore, genetic variants that result in func-
tional differences in enzyme activity lead to differences in 
acetaldehyde exposure between drinkers.Human ALDH2 
gene is located on chromosome 12q24.2 and composed 
of  13 exons, spanning 46,031 bp8. A common SNP is 
at exon 12 results from the substitution of  glutamate(-
Glu) to lysine (Lys) at residue 487 appropriately named 
Glu504Lys(NCBI ID: rs671), which encodes a catalyti-
cally inactive subunit of  ALDH2.The variant 504lys al-
lele decreases the activity of  ALDH2
9, and ALDH2 Glu/
Lys genotype has only 6.25% of  the normal ALDH2 Glu 
proteins10. Previous meta-analysis suggested that ALDH2 
Glu504Lys polymorphism may play crucial roles in the 
pathogenesis of  gastric cancer11.  
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To date, many studies have investigated the interrelation 
between ALDH2 Glu504Lys polymorphism and CRC 
risk. However, the results have been inconsistent. One 
of  the most potential reasons is that the statistical pow-
er is limited for the individual studies. The present com-
prehensive meta-analysis of  currently published studies 
aimed to identify the relationships between the ALDH2 
Glu504Lys polymorphism and the risk of  CRC.
Materials and methods
Search strategy
Extensive literature was retrieved using the PubMed and 
EMBASE databases for relevant studies published (the 
last search update was June 15, 2016) with the following 
key words: (colorectal cancer odds ratio [OR] colorectal 
carcinoma) AND (ALDH or aldehyde dehydrogenases) 
AND (polymorphisms OR variant). The search was not 
limited to language.We contacted the corresponding au-
thor for specific raw data if  the data presented in the ar-
ticle were not sufficient.When overlapping data existed, 




The included studies met all the following inclusion cri-
teria:(a) evaluated the associations of  ALDH2 Glu504Lys 
polymorphism and CRC risk; (b) used case-control or co-
hort design; and (c) provide sufficient data for calculation 
of  odds ratio (OR) with 95% confidence interval (CI).In 
addition,the following exclusion criteria were also used: 
(a) no usable data reported; (b) the study only involved a 




The following information was extracted from each study: 
name of  the first author; year of  publication; country of  
origin; ethnicity; number of  subjects in each category, and 
the counts of  persons with different genotypes in cases 
and controls. Information on the Hardy-Weinberg equi-
librium test (HWE) was also calculated.
 
Quality assessment
The quality of  these articles was also evaluated inde-
pendently by the two investigators according to the pre-
defined quality assessment rules in Table 112.The criteria 
cover the representativeness of  patients, source of  con-
trols, ascertainment of  cancer, total sample size, quality 
control of  genotyping methods, and Hardy-Weinberg 
equilibrium(HWE) in the control population. Disagree-
ments were resolved by consensus. The total score ranged 
from 0 (worst) to 15 (best). Papers scoring <10 were clas-
sified as “low quality” and those scoring ≥10 as “high 
quality.” 
Table 1. Scale for quality assessment 
 
Criteria                                                                                 Score 
Source of cases 
Selected from population or cancer registry                                                    
Selected from hospital                                                                     
Selected from pathological archives, but without a 
description                                         





Source of controls 
Population-based                                                                        
Blood donors or volunteers 






Specimens obtained from patients to determine genotypes 
White blood cells or normal tissues 
Tumor tissues or exfoliated cells of tissue 
3 
0 
Hardy-Weinberg equilibrium in controls 




Total sample size 
≥ 1000 
≥ 500 but < 1000  
≥ 200 but < 500 







All the data was analyzed using Stata 12.0 software (Stata 
Corp., LP, http://www.stata.com; Stata Corporation,Col-
lege Station,TX).The association strength between 
ALDH2 Glu504Lys polymorphism and CRC risks was 
measured by OR with 95%CI).We examined ALDH2 
Glu504Lys polymorphism using the homozygote com-
parison (Lys/Lys vs Glu/Glu), heterozygote comparison 
(Glu/Lys vs Glu/Glu),dominant (Lys/Lys+Glu/Lys vs 
Glu/Glu) and recessive (Lys/Lys vs Glu/Lys+Glu/Glu) 
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models.We also quantified the effects of  heterogeneity 
using the I2 test.When a significant I2>50% indicated 
heterogeneity across studies,either the random effects 
model or the fixed effects model was performed13. Sub-
group analyses were performed by ethnicity and quality 
assessment. A sensitivity analysis was used to evaluate 
the stability of  the results.Publication bias was investigat-
ed using Begg’s funnel plot and Egger’s regression test 
(p<0.05 was considered to be statistically significant).
Results
Study characteristics
The search strategy searched 36 potentially relevant ar-
ticles. According to the inclusion criteria and exclusion 
criteria, nine studies with full text were included in the 
meta-analysis and 27 studies were excluded14-22. These 9 
case-control studies selected included a total of  2779 cas-
es and 4533 healthy controls. A flow chart of  the study 
selection process is summarized in Figure 1.
 
Figure 1 PRISMA Flow Diagram of the meta-analysis. 
The publication years ranged from 1998 to 2012. All the 
studies were published in English. The genotype distribu-
tions in the controls of  all studies were in agreement with 
HWE. General characteristics and the allele and genotype 
distributions in the published articles included in this me-
ta-analysis are shown in Table 2.
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Meta-analysis
A summary of  the meta-analysis findings of  the asso-
ciation between ALDH2 Glu504Lys polymorphism and 
CRC risk is shown in Figure 2-4 and Table 3.When all 
eligible studies were pooled into one dataset for the me-
ta-analysis,we found no statistical association between the 
ALDH2 Glu504Lys polymorphism and CRC risk(Lys/
Lys vs Glu/Glu: OR =0.80, 95%CI =0.55–1.16; Glu/
Lys vs Glu/Glu: OR = 0.84, 95%CI = 0.69–1.01; the 
dominant model: OR =0.84, 95%CI =0.69–1.02; the re-
cessive model: OR =0.87, 95%CI = 0.62–1.23).Sensitivity 
analyses were performed by altering the statistic models.
No material alteration was detected, indicating that our 
results were statistically robust.
 
Table 2. Characteristics of the included studies for meta-analysis 
 








      Glu/Glu  Glu/Lys 
Lys/Lys 
Glu/Glu  Glu/Lys Lys/Lys         
Chiang 
2012  
China 545/103 304      218      23 43      53      7 0.08 11 
Yang 
2009 
China 426/785 274      119      33 489     261     35 0.98 12 
Gao 2008 China 190/222 131      54       5 123     90      9 0.13 12 
Yin 2007 Japan 685/778 400      257      28 416     309     53 
 
  0.67             13 
Matsuo 
2006 
Japan 257/768 129      104      24 383     314     71   0.57 12 
Otani 
2005 
Japan 106/ 224 61       36       9 137     72      15   0.20 10 
Kuriki 
2005 
Japan 72 /116 45       24       3 64      44      8   0.91 9 
Hirose 
2005 
Japan 452/1050 299      137      16 605     390     55   0.44 12 
Yokoyama 
1998 




Figure 2 Forest plot of CRC risk associated with ALDH2 Glu504Lys  
polymorphism in the total population.  
Figure 2 Forest plot of CRC risk associated with ALDH2 Glu504Lys  
polymorphis  in the total population.  
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To explore the sources of  heterogeneity, we performed 
further sub-group analyses by ethnicity and quality as-
sessment of  included studies.In sub-group analysis by 
ethnicity, the studies included were divided into China 
and Japan,and significant association was found between 
ALDH2 Glu504Lys polymorphism and CRC in China(-
Glu/Lys vs Glu/Glu: OR = 0.70, 95%CI = 0.57–0.85; 
the dominant model: OR =0.69, 95%CI =0.48–0.98) and 
Japan(Lys/Lys vs Glu/Glu: OR =0.72, 95%CI =0.55–
0.95).When stratified according to high-quality studies, 
ALDH2 Glu504Lys polymorphism was not associated 
with CRC(Table 3).
 
Figure 3 Forest plot of CRC risk associated with ALDH2 Glu504Lys  
polymorphism in China.  
 
Figure 4 Forest plot of CRC risk associated with ALDH2  
Glu504Lys polymorphism in Japan 
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Publication bias
The Begg’s funnel plot was performed to assess the pub-
lication bias in the reports included for meta-analysis.The 
shapes of  the funnel plots in all genetic models did not 
reveal any evidence of  obvious asymmetry(Figure 5).And 
Egger’s line regression test indicated no significant publi-
cation bias (P > 0.05).
 
Table 3  Summary ORs and 95%CI of ALDH2 Glu504Lys polymorphism with colorectal cancer risk. 
 
Variables N a Lys/Lys vs Glu/Glu Glu/Lys vs Glu/Glu Dominant model Recessive model 
    OR(95%CI)    I2(%) OR(95%CI)  I2(%) OR(95%CI)   I2(%) OR(95%CI)   I2(%) 
Total 9 0.80(0.55–1.16)   57.1 0.84( 0.69–1.01)  59.8 0.84(0.69–1.02)  64.8 0.87(0.62–1.23)  51.7 
Ethnicity           
China 3 0.81(0.31-2.08)   75.0 0.70(0.57-0.85)  33.0 0.69(0.48-0.98)  67.7 0.97(0.43-2.20)   67.6 
Japan 6 0.72(0.55-0.95)  27.3 0.95(0.74-1.21)  62.8 0.94(0.73-1.20)   67.4 0.76(0.58-1.00)   8.4 
Quality           
High-
quality 
8 0.81(0.55-1.21)   62.3 0.84(0.69-1.03)  64.8 0.85(0.69-1.04)   69.1 0.89(0.61-1.28)   57.4 
Low-quality 1      /      /      /      / 
a Number of comparisons. 
 
Figure 5 Begg’s funnel plot for evaluation of publication bias.  
Discussion
CRC is one of  the most common malignancies and rep-
resents a significant cause of  morbidity and mortality 
worldwide. Previous epidemiological evidence demon-
strated that alcohol intake is associated with increased 
CRC risk23. After alcohol is absorbed, the concentration 
of  alcohol in the colon is as high as that found in the 
blood24. Most of  the acetaldehyde generated during al-
cohol metabolism is promptly eliminated by ALDH.
Previous animal experiments have shown that when 
ALDH activity was inhibited, tumorigenesis was ob-
served in the colon of  rats25. Yokoyama et al. first ex-
amined the association between ALDH2 Glu504Lys and 
colon cancer among Japanese alcoholics and reported a 
3-fold increased risk among heterozygotes22. Later, sev-
eral studies,but not all,showed an association of  ALDH2 
Glu504Lys polymorphism with increased risk for CRC.
Furthermore,these results above were based on a small 
sample size, it is possible that the observed associations 
reflect chance observations rather than true associations.
To help resolve these conflicting results,we conducted 
this meta-analysis to get a more authentic result.
The aim of  our meta-analysis was to combine the same 
kind of  studies to increase the sample size and statisti-
cal power, and thereby get a more authentic result. Fi-
nally, 9 case-control studies were included and assessed, 
involving a total of  2779  cases and 4533 healthy con-
trols. Eventually, the results of  the present meta-analysis 
revealed that ALDH2 Glu504Lys polymorphism is not 
associated with increased or decreased risk of  CRC in the 
overall population. Nevertheless, considering that other 
potential confounding factors would influence the result, 
we further conducted several sub-group analyses. In the 
stratified analysis by ethnicity, results showed significant 
association in both China and Japan. This might account 
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for ethnic differences and diverse live environment. The 
mechanism by which the Glu504Lys polymorphism af-
fects CRC risk is currently unclear. As with other diseases, 
the development of  CRC is due to the joint effect of  mul-
tiple genes and gene-environment interactions. Matsuo 
et al. found that heavier drinking, risk genotypes(ADH2 
47His and ALDH2 487Lys), and low folate consumption 
might synergistic increase the risk of  CRC18. As the eligi-
ble study number was limited in the meta-analysis, these 
results still need further investigation.
Limitations
Some limitations of  our meta-analysis should be ad-
dressed. First of  all, studies included in the present me-
ta-analysis mainly provided data towards Asians, other 
ethnicities including Caucasian, and others should be 
investigated in future studies. Second, most of  the men 
had a high frequency of  drinking, while the majority of  
women had a low frequency of  drinking, which may af-
fect the final results. Further stratification analysis should 
aim at gender. Third, the existence of  gene-gene and 
gene-environment interactions may affect the accuracy 
of  our results. Lack of  the relevant data limited our fur-
ther analysis of  potential interactions among gene-gene 
and gene-environment.
Conclusion 
This meta-analysis suggested that the ALDH2 Glu504Lys 
polymorphism may be  associated with CRC risk. Large-
scale case-control and population-based association stud-
ies are warranted to validate the risk identified in the cur-
rent meta-analysis and investigate the potential gene-gene 
and gene-environment interactions on CRC risk.




1. Siegel R, Desantis C, Jemal A.Colorectal cancer statis-
tics, 2014. CA Cancer J Clin 2014; 64:104 – 117. PubMed 
2. Potter JD.Colorectal cancer: molecules and popula-
tions. J Natl Cancer Inst 1999; 91:916-32 PubMed
3. Jemal A1, Bray F, Center MM, et al.Global cancer sta-
tistics. CA Cancer J Clin 2011;61:69– 90. PubMed 
4. Gao X, Duan H, Zhu Z. Association between PTEN 
IVS4 polymorphism and cancer risk: a meta-analysis. 
Cancer Biomark 2013;13:465–470.  PubMed
5. Lichtenstein P, Holm NV, Verkasalo PK,et al.Envi-
ronmental and heritable factors in the causation of  can-
cer-analyses of  cohorts of  twins from Sweden, Denmark, 
and Finland. N Engl J Med 2000;343:78–85.  PubMed
6. Whiffin N, Hosking FJ, Farrington SM, et al.Identifi-
cation of  susceptibility loci for colorectal cancer in a ge-
nome-wide meta-analysis. Hum Mol Genet 2014;23:4729-
4737 PubMed .
7. Edenberg HJ.The genetics of  alcohol metabolism: role 
of  alcohol dehydrogenase and aldehyde dehydrogenase 
variants. Alcohol Res Health 2007;30:5e13.
8. Yoshida A, Rzhetsky A, Hsu LC, Chang C.Human al-
dehyde dehydrogenase gene family. Eur J Biochem 1998; 
251: 549–557. PubMed 
9. Wang RS, Nakajima T, Kawamoto T, Honma T.Effects 
of  aldehyde dehydrogenase-2 genetic polymorphisms on 
metabolism of  structurally different aldehydes in human 
liver. Drug Metab Dispos 2002;30:69e73.
10. Crabb DW, Edenberg HJ, Bosron WF, Li TK.Geno-
types for aldehyde dehydrogenase deficiency and alcohol 
sensitivity. The inactive ALDH2(2) allele is dominant. J 
Clin Invest 1989;83: 314-316 PubMed .
11. Wang HL, Zhou PY, Liu P, Zhang Y.ALDH2 and 
ADH1 genetic polymorphisms may contribute to 
the risk of  gastric cancer: a meta-analysis. PLoS One 
2014;9:e88779.
12. Jiang DK, Ren WH, Yao L, et al.Meta-analysis of  as-
sociation between TP53 Arg72Pro polymorphism and 
bladder cancer risk.Urology 2012;76:765. e1-7. PubMed
13. DerSimonian R, Laird N.Meta-analysis in clinical tri-
als. Control Clin Trials 1986;7: 177-188 PubMed .
14. Chiang CP, Jao SW, Lee SP, et al.Expression pattern, 
ethanol-metabolizing activities, and cellular localization 
of  alcohol and aldehyde dehydrogenases in human large 
bowel: association of  the functional polymorphisms of  
ADH and ALDH genes with hemorrhoids and colorectal 
cancer. Alcohol 2012;46:37-49 PubMed .
15. Yang H, Zhou Y, Zhou Z,et al.A novel polymorphism 
rs1329149 of  CYP2E1 and a known polymorphism rs671 
of  ALDH2 of  alcohol metabolizing enzymes are asso-
ciated with colorectal cancer in a southwestern Chinese 
population. Cancer Epidemiol Biomarkers Prev 2009;18:2522-
2527.
16. Gao CM, Takezaki T, Wu JZ, et al.Polymorphisms of  
alcohol dehydrogenase 2 and aldehyde dehydrogenase 2 
and colorectal cancer risk in Chinese males.World J Gastro-
enterol 2008;14:5078-5083.
17. Yin G, Kono S, Toyomura K,et al.Alcohol dehydro-
genase and aldehyde dehydrogenase polymorphisms and 
African Health Sciences Vol 17 Issue 1, March, 2017114
colorectal cancer: the Fukuoka Colorectal Cancer Study.
Cancer Sci 2007;98:1248-1253 PubMed .
18. Matsuo K, Wakai K, Hirose K, et al.A gene-gene in-
teraction between ALDH2 Glu487Lys and ADH2 His-
47Arg polymorphisms regarding the risk of  colorectal 
cancer in Japan. Carcinogenesis 2006;27:1018-1023 PubMed 
19. Otani T, Iwasaki M, Hanaoka T,et al.Folate, vitamin 
B6, vitamin B12, and vitamin B2 intake, genetic polymor-
phisms of  related enzymes, and risk of  colorectal cancer 
in a hospital-based case-control study in Japan. Nutr Can-
cer 2005;53:42-50 PubMed .
20. Kuriki K, Hamajima N, Chiba H, et al.Relation of  the 
CD36 gene A52C polymorphism to the risk of  colorectal 
cancer among Japanese, with reference to with the alde-
hyde dehydrogenase 2 gene Glu487Lys polymorphism 
and drinking habit. Asian Pac J Cancer Prev 2005;6:62-68.
21. Hirose M, Kono S, Tabata S, et al.Genetic polymor-
phisms of  methylenetetrahydrofolate reductase and alde-
hyde dehydrogenase 2, alcohol use and risk of  colorectal 
adenomas: Self-Defense Forces Health Study. Cancer Sci 
2005;96:513-518 PubMed .
22. Yokoyama A, Muramatsu T, Ohmori T, et al.Alco-
hol-related cancers and aldehyde dehydrogenase-2 in 
Japanese alcoholics. Carcinogenesis 1998;19:1383-1387 
PubMed 
23. Seitz HK, Simanowski UA, Garzon FT, et al.Possi-
ble role of  acetaldehyde in ethanol-related rectal cocar-
cinogenesis in the rat. Gastroenterology 1990;98:406–413. 
PubMed
24. Erikson CJ.The role of  acetaldehyde in the actions of  
alcohol (update 2000). Alcohol Clin Exp Res 2001;25:S15–
32.
25. Luo HR, Israel Y, Tu GC, et al.Genetic polymorphism 
of  aldehyde dehydrogenase 2 (ALDH2) in a Chinese pop-
ulation:gender, age, culture, and genotypes of  ALDH2. 
Biochem Genet 2005;43: 223–227. PubMed 
African Health Sciences Vol 17 Issue 1, March, 2017     115
